BINGHAM COUNTY CANCER PROFILE

Similar documents
NEZ PERCE COUNTY CANCER PROFILE

KOOTENAI COUNTY CANCER PROFILE

TWIN FALLS COUNTY CANCER PROFILE

JEROME COUNTY CANCER PROFILE

BUTTE COUNTY CANCER PROFILE

LINCOLN COUNTY CANCER PROFILE

CANYON COUNTY CANCER PROFILE

NEZ PERCE COUNTY CANCER PROFILE

KOOTENAI COUNTY CANCER PROFILE

BOUNDARY COUNTY CANCER PROFILE

ADAMS COUNTY CANCER PROFILE

BONNER COUNTY CANCER PROFILE

Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho

Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho

What is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*

CANCER FACTS & FIGURES For African Americans

Epidemiology in Texas 2006 Annual Report. Cancer

BREAST CANCER IN IDAHO

Cancer Facts & Figures for African Americans

*

Cancer in New Mexico 2017

Common Questions about Cancer

Cancer in New Mexico 2014

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004

SMOKING AND CANCER RISK

SMOKING AND CANCER RISK

Colorectal Cancer Screening

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

The Face of Cancer in Montgomery County Ohio: A Look at the Population at Risk

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

Samuel M. Lesko, MD, MPH Director of Research/Medical Director

This report was made possible by Summit County Public Health s Cancer Concerns Assessment Team. Special thanks for their contribution and assistance

Cancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Table of Contents. 2 P age. Susan G. Komen

Community Health Assessment Ontario County Chronic Diseases

Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials

Alabama Cancer Facts & Figures 2009

Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts

Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer

Information Services Division NHS National Services Scotland

Prediction of Cancer Incidence and Mortality in Korea, 2018

Cancer in Maine: Using Data to Direct Actions 2018 Challenge Cancer Conference May 1, 2018

Cancer Dispari,es in Indiana

CANCER. in north carolina Report. cancer and income with a special report on cancer, income, and racial differences

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

National Cancer Statistics in Korea, 2014

Cancer Facts & Figures for African Americans

Prediction of Cancer Incidence and Mortality in Korea, 2013

Information Services Division NHS National Services Scotland

Burden of Cancer in California

A New Measure to Assess the Completeness of Case Ascertainment

NIH Public Access Author Manuscript Cancer. Author manuscript; available in PMC 2006 December 17.

Cancer prevalence. Chapter 7

APPENDIX ONE: ICD CODES

Bioengineering and World Health. Lecture Twelve

Cancer in the Northern Territory :

Epidemiology of Cancer

ANNUAL CANCER REGISTRY REPORT-2005

Impact and implications of Cancer Death Status Reporting Delay on Population- Based Relative Survival Analysis with Presumed-Alive Assumption

Outcomes Report: Accountability Measures and Quality Improvements

Colorectal Cancer Screening

Cancer Prevention: the gap between what we know and what we do

Colorectal Cancer in Idaho November 2, 2006 Chris Johnson, CDRI

Chapter II: Overview

Information Services Division NHS National Services Scotland

Cancer Incidence and Mortality in the City of Cleveland

Cancer Statistics, 2011

Metropolitan and Micropolitan Statistical Area Cancer Incidence: Late Stage Diagnoses for Cancers Amenable to Screening, Idaho

CHRONIC DISEASE San Luis Obispo County 59 photo credit: Barbara J. Schanz

Detection: Rabab Gaafar,MD. Prof. Medical Oncology NCI,Cairo, Cairo University

Achieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016

chapter 8 CANCER Is cancer becoming more common? Yes and No.

Cancer in Utah: An Overview of Cancer Incidence and Mortality from

Health Promotion, Screening, & Early Detection

Potentially preventable cancers among Alaska Native people

Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group

North Central Florida Cancer Report 2013

Cancer A Superficial Introduction

Epidemiology of Cancer 8/31/17

The Greater Bay Area Cancer Registry Annual Report: Incidence and Mortality Review,

Public Health. W a k e C o u n t y H u m a n S e r v i c e s P u b l i c H e a l t h Q u a r t e r l y R e p o r t. Prevent. Promote.

Idaho Comprehensive Cancer. Strategic Plan

Overview of 2010 Hong Kong Cancer Statistics

Florida Cancer Data System STAT File Documentation Version 2019

Cancer in Halton. Halton Region Cancer Incidence and Mortality Report

Cancer in Estonia 2014

CANCER IN IDAHO 2016 Preliminary

Annual Report to the Nation on the Status of Cancer, , Featuring Survival Questions and Answers

Overview of Gynecologic Cancers in New Jersey

Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group

Cancer in Colorado Incidence, Mortality, and Survival

Cancer Health Disparities in Tarrant County

Cancer Statistics, 2008

Alabama Cancer Facts & Figures ACS

CANCER INCIDENCE NEAR THE BROOKHAVEN LANDFILL

Transcription:

BINGHAM COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group of more than 100 different diseases, each characterized by uncontrolled growth and spread of abnormal cells. Cancer risk increases with age and varies by gender and race. As the average age of the population increases, the incidence of cancer will increase as well. It is generally accepted that 65-80% of all cancers are related to personal lifestyle or environmental factors, such as smoking and diet, and are therefore preventable. Other factors such as age, gender, and family history of specific cancers are also associated with cancer and aid in the identification of people at high risk. For some cancers, effective treatment is available. For these cancers, early detection can save lives. For example, there is convincing evidence that screening for colorectal cancer reduces mortality in adults aged 50 to 75 years. Through improved prevention, early detection, and treatment, opportunities exist to lessen the burden of cancer in Idaho. RISK FACTORS AND INTERVENTIONS Aging: Because the population is aging, the number of new cancer cases and cancer deaths that occur each year will continue to increase unless the trend is reversed by significant improvements in prevention, early detection, and treatment. Smoking: Smoking and the use of smokeless tobacco are responsible for the majority of all cancers of the lung, trachea, bronchus, larynx, pharynx, oral cavity, and esophagus. Smoking is the leading cause of preventable death in the United States. Diet: The U.S. Department of Agriculture recommends the following dietary guidelines for managing a healthy diet: eat a variety of foods; maintain a healthy weight; choose a diet with plenty of fruits, vegetables, and whole-grain products; limit the use of sugar, sodium (salt), solid fats, and refined grains; and minimize alcoholic beverage consumption. Screening: Early detection is extremely important for those cancers that can be cured and which can be discovered early. FOR MORE INFORMATION Cancer Data Registry of Idaho 615 N. 7 th Street P.O. Box 1278 Boise, ID 83701 208-489-1380 https://www.idcancer.org National Cancer Institute Cancer Information Services 1-800-4CANCER https://www.cancer.gov/contact/contact -center American Cancer Society 2676 S. Vista Avenue Boise, ID 83705 208-343-4609 https://www.cancer.org 1

CANCER INCIDENCE 2011-2015 During the five-year period 2011-2015, 38,676 cases of invasive cancer were diagnosed among residents of the state of Idaho, 922 among Bingham County residents. It is estimated that almost one in two Idahoans will develop cancer during their lifetime. Cancer Incidence 2011-2015 Bingham County State of Idaho All Sites/Types 922 38,676 Female Breast 136 5,487 Prostate 125 5,021 Lung & Bronchus 77 4,493 Colorectal 94 3,151 The table, CANCER INCIDENCE 2011-2015, COMPARISON BETWEEN BINGHAM COUNTY AND THE REMAINDER OF THE STATE OF IDAHO, shows for Bingham County the number of observed cases, person-years, crude rates, age and sex-adjusted rates, expected number of cases based upon age and sex-specific rates in the remainder of Idaho, and p-values for tests comparing the number of observed and expected cases. The table also shows the number of observed cases, person-years, and crude rates for the remainder of the state of Idaho. Comparisons were made for all cancers combined, 23 invasive cancer types, in situ breast cancer, non-malignant brain and other central nervous system tumors, and pediatric cancer. Separate comparisons for males, females, and both sexes combined are included. As the table shows, the crude rate of invasive cancer incidence in Bingham County was 406.1 cases per 100,000 person-years for the years 2011-2015. Compared with the crude incidence rate for the remainder of Idaho (480.9), this gives an estimate of the burden of disease in Bingham County. The age- and sex-adjusted incidence rate of invasive cancer in Bingham County, all sites combined, was 440.3 cases per 100,000 persons per year for the years 2011-2015. There were statistically significantly fewer cases of cancer in Bingham County (922) than expected (1,006.9) based upon rates in the remainder of the state (p=.007). There are many reasons why cancer incidence rates differ by county, related to smoking, other personal behaviors, socioeconomic status, and other factors. CANCER MORTALITY 2012-2016 In 2008 cancer became the leading cause of death in Idaho. From 2012-2016, 13,799 persons in Idaho died from cancer, 337 in Bingham County. The majority of cancer deaths are from five primary sites: lung, colon, pancreas, female breast, and prostate. Mortality 2012-2016 Bingham County State of Idaho All Deaths 1,760 63,430 Cancer Deaths % of All Deaths 337 19.1% 13,799 21.8% Lung & Bronchus 57 3,135 Colorectal 31 1,165 Pancreas 28 1,025 Female Breast 23 965 The table, CANCER MORTALITY 2012-2016, COMPARISON BETWEEN BINGHAM COUNTY AND THE REMAINDER OF THE STATE OF IDAHO, shows for Bingham County the number of observed deaths, person-years, crude rates, age and sex-adjusted rates, expected number of deaths based upon age and sex-specific rates in the remainder of Idaho, and p-values for tests comparing the number of observed and expected deaths. The table also shows the number of observed deaths, person-years, and crude rates for the remainder of the state of Idaho. Comparisons were made for all deaths, all cancer deaths, and 21 specific cancer types. Separate comparisons for males, females, and both sexes combined are included. The age- and sex-adjusted cancer mortality rate for Bingham County, all sites combined, was 161.7 deaths per 100,000 persons per year for the years 2012-2016, compared with 169.3 for the remainder of the state. There were fewer cancer deaths in Bingham County (337) than expected (352.9) based upon rates in the remainder of the state, but the difference was not statistically significant. Prostate 27 881 Statistical Note: Rates and percentages based upon 12 or fewer cases or deaths (numerator) should be interpreted with caution. Data Note: Mortality data may differ slightly from published official statistics from the Bureau of Vital Records and Health Statistics. 2

CANCER INCIDENCE 2011-2015 COMPARISON BETWEEN BINGHAM COUNTY AND THE REMAINDER OF THE STATE OF IDAHO Bingham County Remainder of Idaho Cancer Observed Person Crude A.A.I. Expected Observed Person Crude Site/Type Sex Cases Years Rate (1) Rate (1,2) Cases (3) P-Value (4) Cases Years Rate (1) All Sites Combined Total 922 227,016 406.1 440.3 1,006.9 0.007 << 37,754 7,851,409 480.9 All Sites Combined Male 464 113,999 407.0 437.3 526.2 0.006 << 19,506 3,933,049 496.0 All Sites Combined Female 458 113,017 405.2 441.7 482.9 0.266 18,248 3,918,360 465.7 Bladder Total 38 227,016 16.7 18.2 49.3 0.117 1,855 7,851,409 23.6 Bladder Male 30 113,999 26.3 28.2 39.1 0.159 1,446 3,933,049 36.8 Bladder Female 8 113,017 7.1 7.8 10.6 0.530 409 3,918,360 10.4 Brain - malignant Total 10 227,016 4.4 4.6 15.5 0.194 560 7,851,409 7.1 Brain - malignant Male 7 113,999 6.1 6.5 9.4 0.563 340 3,933,049 8.6 Brain - malignant Female 3 113,017 2.7 2.8 6.1 0.283 220 3,918,360 5.6 Brain and other CNS - non-malignant Total 21 227,016 9.3 10.0 24.7 0.531 924 7,851,409 11.8 Brain and other CNS - non-malignant Male 7 113,999 6.1 6.5 8.5 0.769 313 3,933,049 8.0 Brain and other CNS - non-malignant Female 14 113,017 12.4 13.5 16.1 0.707 611 3,918,360 15.6 Breast Total 136 227,016 59.9 65.0 143.7 0.553 5,392 7,851,409 68.7 Breast Male - 113,999 - - 1.1 0.663 41 3,933,049 1.0 Breast Female 136 113,017 120.3 131.3 141.4 0.686 5,351 3,918,360 136.6 Breast - in situ Total 25 227,016 11.0 12.0 27.4 0.737 1,031 7,851,409 13.1 Breast - in situ Male - 113,999 - - 0.1 1.000 3 3,933,049 0.1 Breast - in situ Female 25 113,017 22.1 24.2 27.1 0.774 1,028 3,918,360 26.2 Cervix Female 3 113,017 2.7 2.8 6.4 0.235 238 3,918,360 6.1 Colorectal Total 94 227,016 41.4 44.9 81.5 0.189 3,057 7,851,409 38.9 Colorectal Male 55 113,999 48.2 51.8 43.0 0.087 1,591 3,933,049 40.5 Colorectal Female 39 113,017 34.5 37.7 38.7 0.999 1,466 3,918,360 37.4 Corpus Uteri Female 29 113,017 25.7 28.0 28.6 0.988 1,083 3,918,360 27.6 Esophagus Total 8 227,016 3.5 3.8 10.7 0.520 402 7,851,409 5.1 Esophagus Male 6 113,999 5.3 5.6 9.0 0.419 332 3,933,049 8.4 Esophagus Female 2 113,017 1.8 2.0 1.8 1.000 70 3,918,360 1.8 Hodgkin Lymphoma Total 5 227,016 2.2 2.3 5.6 1.000 201 7,851,409 2.6 Hodgkin Lymphoma Male 2 113,999 1.8 1.8 3.2 0.747 117 3,933,049 3.0 Hodgkin Lymphoma Female 3 113,017 2.7 2.8 2.3 0.822 84 3,918,360 2.1 Kidney and Renal Pelvis Total 32 227,016 14.1 15.3 36.9 0.479 1,381 7,851,409 17.6 Kidney and Renal Pelvis Male 22 113,999 19.3 20.7 23.7 0.825 880 3,933,049 22.4 Kidney and Renal Pelvis Female 10 113,017 8.8 9.6 13.3 0.459 501 3,918,360 12.8 Larynx Total 4 227,016 1.8 1.9 5.2 0.803 197 7,851,409 2.5 Larynx Male 3 113,999 2.6 2.8 4.4 0.723 164 3,933,049 4.2 Larynx Female 1 113,017 0.9 1.0 0.9 1.000 33 3,918,360 0.8 Leukemia Total 31 227,016 13.7 14.5 36.9 0.378 1,351 7,851,409 17.2 Leukemia Male 16 113,999 14.0 14.7 21.3 0.291 772 3,933,049 19.6 Leukemia Female 15 113,017 13.3 14.2 15.6 1.000 579 3,918,360 14.8 Liver and Bile Duct Total 17 227,016 7.5 8.1 16.4 0.941 613 7,851,409 7.8 Liver and Bile Duct Male 9 113,999 7.9 8.4 11.8 0.512 437 3,933,049 11.1 Liver and Bile Duct Female 8 113,017 7.1 7.8 4.6 0.191 176 3,918,360 4.5 Lung and Bronchus Total 77 227,016 33.9 36.9 117.2 0.000 << 4,416 7,851,409 56.2 Lung and Bronchus Male 43 113,999 37.7 40.5 61.6 0.016 << 2,282 3,933,049 58.0 Lung and Bronchus Female 34 113,017 30.1 33.1 55.9 0.002 << 2,134 3,918,360 54.5 Melanoma of the Skin Total 45 227,016 19.8 21.5 61.3 0.036 << 2,298 7,851,409 29.3 Melanoma of the Skin Male 18 113,999 15.8 17.0 36.1 0.001 << 1,340 3,933,049 34.1 Melanoma of the Skin Female 27 113,017 23.9 25.9 25.5 0.819 958 3,918,360 24.4 Myeloma Total 11 227,016 4.8 5.3 14.0 0.513 527 7,851,409 6.7 Myeloma Male 5 113,999 4.4 4.7 8.6 0.287 319 3,933,049 8.1 Myeloma Female 6 113,017 5.3 5.8 5.5 0.944 208 3,918,360 5.3 Non-Hodgkin Lymphoma Total 38 227,016 16.7 18.1 42.9 0.513 1,600 7,851,409 20.4 Non-Hodgkin Lymphoma Male 27 113,999 23.7 25.3 24.5 0.665 903 3,933,049 23.0 Non-Hodgkin Lymphoma Female 11 113,017 9.7 10.6 18.5 0.088 697 3,918,360 17.8 Oral Cavity and Pharynx Total 20 227,016 8.8 9.5 28.0 0.146 1,049 7,851,409 13.4 Oral Cavity and Pharynx Male 12 113,999 10.5 11.3 19.4 0.103 717 3,933,049 18.2 Oral Cavity and Pharynx Female 8 113,017 7.1 7.8 8.7 0.981 332 3,918,360 8.5 Ovary Female 20 113,017 17.7 19.3 13.0 0.085 491 3,918,360 12.5 Pancreas Total 35 227,016 15.4 16.8 29.8 0.386 1,125 7,851,409 14.3 Pancreas Male 25 113,999 21.9 23.6 16.4 0.057 609 3,933,049 15.5 Pancreas Female 10 113,017 8.8 9.8 13.5 0.430 516 3,918,360 13.2 Prostate Male 125 113,999 109.7 119.1 130.6 0.661 4,896 3,933,049 124.5 Stomach Total 11 227,016 4.8 5.3 11.5 1.000 432 7,851,409 5.5 Stomach Male 6 113,999 5.3 5.6 7.8 0.680 288 3,933,049 7.3 Stomach Female 5 113,017 4.4 4.9 3.8 0.649 144 3,918,360 3.7 Testis Male 6 113,999 5.3 5.7 6.8 0.950 257 3,933,049 6.5 Thyroid Total 53 227,016 23.3 25.1 32.8 0.001 >> 1,222 7,851,409 15.6 Thyroid Male 7 113,999 6.1 6.6 7.6 1.000 285 3,933,049 7.2 Thyroid Female 46 113,017 40.7 43.5 25.3 0.000 >> 937 3,918,360 23.9 Pediatric Age 0 to 19 Total 9 78,824 11.4 11.5 14.0 0.217 411 2,290,945 17.9 Pediatric Age 0 to 19 Male 6 40,747 14.7 14.9 7.4 0.772 216 1,171,859 18.4 Pediatric Age 0 to 19 Female 3 38,077 7.9 7.9 6.6 0.212 195 1,119,086 17.4 Notes: 1. Rates are expressed as the number of cases per 100,000 persons per year (person-years). 2. Age and sex-adjusted incidence (A.A.I.) rates for county use age and sex-specific crude rates for the remainder of the state as standard. 3. Expected cases are based upon age and sex-specific rates for the remainder of the state of Idaho (compare to observed). 4. P-values compare observed and expected cases, are two tailed, based upon the Poisson probability distribution. "<<" denotes significantly fewer cases observed than expected, ">>" denotes significantly more cases observed than expected (p=.05). Statistical Note: Rates based upon 12 or fewer cases (numerator) should be interpreted with caution. 3

CANCER MORTALITY 2012-2016 COMPARISON BETWEEN BINGHAM COUNTY AND THE REMAINDER OF THE STATE OF IDAHO Bingham County Remainder of Idaho Cause of Death Observed Person Crude A.A.M. Expected Observed Person Crude Cancer Site/Type Sex Deaths Years Rate (1) Rate (1,2) Deaths (3) P-Value (4) Deaths Years Rate (1) All Causes of Death Total 1,760 226,306 777.7 844.5 1,616.5 0.000 >> 61,670 7,951,116 775.6 All Causes of Death Male 914 113,613 804.5 848.2 865.0 0.101 31,977 3,983,489 802.7 All Causes of Death Female 846 112,693 750.7 838.9 754.7 0.001 >> 29,693 3,967,627 748.4 All Malignant Cancers Total 337 226,306 148.9 161.7 352.9 0.414 13,462 7,951,116 169.3 All Malignant Cancers Male 190 113,613 167.2 177.9 194.9 0.762 7,269 3,983,489 182.5 All Malignant Cancers Female 147 112,693 130.4 143.9 159.5 0.344 6,193 3,967,627 156.1 Bladder Total 7 226,306 3.1 3.4 9.8 0.483 375 7,951,116 4.7 Bladder Male 6 113,613 5.3 5.6 7.5 0.744 280 3,983,489 7.0 Bladder Female 1 112,693 0.9 1.0 2.4 0.622 95 3,967,627 2.4 Brain and Other Nervous System Total 12 226,306 5.3 5.7 12.0 1.000 454 7,951,116 5.7 Brain and Other Nervous System Male 6 113,613 5.3 5.7 7.7 0.695 290 3,983,489 7.3 Brain and Other Nervous System Female 6 112,693 5.3 5.8 4.3 0.530 164 3,967,627 4.1 Breast Total 23 226,306 10.2 11.0 24.9 0.803 950 7,951,116 11.9 Breast Male - 113,613 - - 0.2 1.000 8 3,983,489 0.2 Breast Female 23 112,693 20.4 22.5 24.3 0.895 942 3,967,627 23.7 Cervix Female - 112,693 - - 2.0 0.262 77 3,967,627 1.9 Colorectal Total 31 226,306 13.7 14.8 29.8 0.872 1,134 7,951,116 14.3 Colorectal Male 22 113,613 19.4 20.6 16.7 0.244 622 3,983,489 15.6 Colorectal Female 9 112,693 8.0 8.8 13.1 0.313 512 3,967,627 12.9 Corpus Uteri Female 5 112,693 4.4 4.9 3.1 0.406 121 3,967,627 3.0 Esophagus Total 8 226,306 3.5 3.8 10.3 0.592 395 7,951,116 5.0 Esophagus Male 8 113,613 7.0 7.5 8.3 1.000 310 3,983,489 7.8 Esophagus Female - 112,693 - - 2.2 0.226 85 3,967,627 2.1 Hodgkin Lymphoma Total 1 226,306 0.4 0.5 0.6 0.927 24 7,951,116 0.3 Hodgkin Lymphoma Male 1 113,613 0.9 0.9 0.3 0.509 11 3,983,489 0.3 Hodgkin Lymphoma Female - 112,693 - - 0.3 1.000 13 3,967,627 0.3 Kidney Total 8 226,306 3.5 3.8 9.0 0.905 345 7,951,116 4.3 Kidney Male 5 113,613 4.4 4.7 6.1 0.868 227 3,983,489 5.7 Kidney Female 3 112,693 2.7 3.0 3.0 1.000 118 3,967,627 3.0 Larynx Total 1 226,306 0.4 0.5 1.6 1.000 60 7,951,116 0.8 Larynx Male - 113,613 - - 1.3 0.526 50 3,983,489 1.3 Larynx Female 1 112,693 0.9 1.0 0.3 0.457 10 3,967,627 0.3 Leukemia Total 12 226,306 5.3 5.7 14.6 0.601 556 7,951,116 7.0 Leukemia Male 5 113,613 4.4 4.7 8.9 0.241 332 3,983,489 8.3 Leukemia Female 7 112,693 6.2 6.8 5.8 0.723 224 3,967,627 5.6 Liver and Bile Duct Total 16 226,306 7.1 7.7 13.8 0.623 526 7,951,116 6.6 Liver and Bile Duct Male 7 113,613 6.2 6.6 9.5 0.543 355 3,983,489 8.9 Liver and Bile Duct Female 9 112,693 8.0 8.8 4.4 0.071 171 3,967,627 4.3 Lung and Bronchus Total 57 226,306 25.2 27.4 80.6 0.007 << 3,078 7,951,116 38.7 Lung and Bronchus Male 32 113,613 28.2 30.1 44.1 0.070 1,652 3,983,489 41.5 Lung and Bronchus Female 25 112,693 22.2 24.5 36.7 0.054 1,426 3,967,627 35.9 Melanoma of the Skin Total 12 226,306 5.3 5.7 7.8 0.192 296 7,951,116 3.7 Melanoma of the Skin Male 9 113,613 7.9 8.5 5.1 0.146 190 3,983,489 4.8 Melanoma of the Skin Female 3 112,693 2.7 2.9 2.7 1.000 106 3,967,627 2.7 Myeloma Total 3 226,306 1.3 1.4 7.9 0.090 299 7,951,116 3.8 Myeloma Male 1 113,613 0.9 0.9 4.7 0.101 175 3,983,489 4.4 Myeloma Female 2 112,693 1.8 1.9 3.2 0.750 124 3,967,627 3.1 Non-Hodgkin Lymphoma Total 10 226,306 4.4 4.8 14.2 0.330 541 7,951,116 6.8 Non-Hodgkin Lymphoma Male 4 113,613 3.5 3.7 8.2 0.179 305 3,983,489 7.7 Non-Hodgkin Lymphoma Female 6 112,693 5.3 5.9 6.0 1.000 236 3,967,627 5.9 Oral Cavity and Pharynx Total 7 226,306 3.1 3.4 5.1 0.507 195 7,951,116 2.5 Oral Cavity and Pharynx Male 7 113,613 6.2 6.6 3.5 0.127 131 3,983,489 3.3 Oral Cavity and Pharynx Female - 112,693 - - 1.7 0.380 64 3,967,627 1.6 Ovary Female 12 112,693 10.6 11.7 10.1 0.637 393 3,967,627 9.9 Pancreas Total 28 226,306 12.4 13.5 26.1 0.757 997 7,951,116 12.5 Pancreas Male 20 113,613 17.6 18.9 14.5 0.194 543 3,983,489 13.6 Pancreas Female 8 112,693 7.1 7.9 11.6 0.360 454 3,967,627 11.4 Prostate Male 27 113,613 23.8 25.1 23.1 0.466 854 3,983,489 21.4 Stomach Total 3 226,306 1.3 1.4 5.4 0.432 204 7,951,116 2.6 Stomach Male - 113,613 - - 3.6 0.055 133 3,983,489 3.3 Stomach Female 3 112,693 2.7 2.9 1.8 0.553 71 3,967,627 1.8 Notes: 1. Rates are expressed as the number of cases per 100,000 persons per year (person-years). 2. Age and sex-adjusted mortality (A.A.M.) rates for county use age and sex-specific crude rates for the remainder of the state as standard. 3. Expected cases are based upon age and sex-specific rates for the remainder of the state of Idaho (compare to observed). 4. P-values compare observed and expected cases, are two tailed, based upon the Poisson probability distribution. "<<" denotes significantly fewer cases observed than expected, ">>" denotes significantly more cases observed than expected (p=.05). Statistical Notes: Rates based upon 12 or fewer cases (numerator) should be interpreted with caution. Mortality statistics presented differ from BVRHS official statistics due to differences in methodology. Data Source: Bureau of Vital Records and Health Statistics (BVRHS), Division of Public Health, Idaho Department of Health and Welfare, 2017. 4

Cancer Screening and Risk Factors The Bureau of Vital Records and Health Statistics (BVRHS), Division of Public Health, Idaho Department of Health and Welfare, under a cooperative agreement with the Centers for Disease Control and Prevention, has conducted telephone Behavioral Risk Factor Surveys (BRFS) since 1984 of random samples of adult Idahoans to measure population prevalences of risk factors for the major causes of death, including cancer. The BVRHS provided data sets containing Behavioral Risk Factor Surveillance System (BRFSS) data from 2011 through 2016 to CDRI staff, who performed the analyses reported in these County Profiles. Analysis weights were poststratified to 2016 population estimates by age group, sex, and county, beginning with the BRFSS raked weights. Not all questions were asked in all years. A minimum of 50 respondents was required to generate county-level statistics. Results may differ from IDHW reports due to differences in methods. The cancer screening and risk factor measures were selected to assist in monitoring Comprehensive Cancer Alliance for Idaho objectives. Wald log-linear chi-square statistics were used to test for independence of the selected measures and other variables such as age and race, taking into account the complex survey design. Cancer Screening and Risk Factor Prevalence Estimates, 2011-2016 State of Idaho HD 1 HD 2 HD 3 HD 4 HD 5 HD 6 HD 7 Bingham County Access to Care Health Insurance, Age <65 (2014-2016) 81.4% 80.1% 84.9% 73.9% 86.5% 73.3% 83.4% 83.5% 79.5% Not See Doctor Due to Cost Past Year (2014-2016) 14.3% 14.0% 10.9% 19.0% 13.2% 14.7% 13.0% 13.8% 13.5% Cancer Screening Mammogram Past 2 Years, Age 50-74 (2014, 2016) 67.0% 66.4% 69.7% 64.0% 71.3% 61.8% 63.1% 67.8% 62.7% Pap Test Past 3 Years, Cervix Intact Age 21-65 (2012, 2014, 2016) 75.2% 75.8% 80.1% 69.0% 78.9% 72.9% 75.7% 72.0% 75.3% Colorectal Cancer Screening, Age 50-75 (2012, 2014, 2016) 62.3% 62.4% 65.4% 57.8% 66.5% 59.2% 59.7% 61.0% 47.1% Tobacco Use Current Smoker (2014-2016) 14.7% 17.5% 14.8% 18.8% 12.1% 17.5% 14.2% 10.1% 16.6% Current Smokeless Tobacco User, Males (2012-2016) 9.6% 10.2% 15.4% 11.3% 8.6% 10.1% 7.8% 7.3% 7.7% Other Cancer-Related Sunburn in Previous 12 Months (2016) 24.4% 25.6% 24.6% 18.6% 21.9% 26.4% 29.6% 30.8% 34.0% Artificial Tanning Appliance Use (2011, 2014, 2016) 4.4% 5.6% 3.3% 3.3% 3.5% 4.2% 5.7% 6.8% 5.6% Weight Classification by Body Mass Index, Age 20+ (2013-2016) 32.7% 34.1% 35.5% 26.6% 36.5% 29.5% 31.1% 32.2% 28.6% Meet Physical Activity Guidelines (2011, 2013, 2015) 21.5% 21.1% 18.2% 19.0% 25.7% 19.1% 20.6% 19.6% 17.5% Home Ever Tested for Radon (2014, 2016) 18.6% 25.5% 13.7% 12.6% 20.2% 16.1% 20.4% 18.5% 20.0% Access to Care Health Insurance 2014-2016 Statewide, 81.4% of adults aged 18-64 reported having health care coverage. Health care coverage differed significantly by race/ethnicity, with 84.3% of white non-hispanics, compared to 61.3% of Hispanics and 87.1% of Native Americans, having health insurance. Spanish-speaking respondents were significantly less likely to be insured (34.5%) than Englishspeaking respondents (83.2%). Health care coverage differed significantly by age of respondent, with 77.8% of persons aged 18-29, and 86.6% of persons aged 50-64, having health insurance. Health care coverage differed significantly by county, with a range of 63.7% (Jerome County) to 94.3% (Caribou County) having health insurance. Not See Doctor Due to Cost Past Year 2014-2016 Statewide, 14.3% of adults aged 18+ reported they needed to see a doctor but could not because of cost sometime in the past 12 months. Inability to see a doctor due to cost differed significantly by race/ethnicity (13.3% of white non-hispanics, 22.9% of Hispanics, and 15.9% of Native Americans). Inability to see a doctor due to cost differed significantly by annual household income (29.1% for less than $15,000, 7.1% for greater than $50,000). Inability to see a doctor due to cost differed significantly by county, with a range of 3.9% (Butte County) to 21.0% (Jerome County). ** Current for colorectal cancer screening means a blood stool test in the past year, sigmoidoscopy in the past 5 years and blood stool test in the past 3 years, or a colonoscopy in the past 10 years. Cancer Screening Mammogram 2014, 2016 Statewide, 67.0% of women aged 50-74 reported having a mammogram in the past 2 years. Insured women were about twice as likely to have had a mammogram in the past 2 years (70.4% versus 32.8%). Mammography rates differed significantly by county, with a range in screening of 62.7% (Bingham County) to 76.0% (Nez Perce County). In 2016, Idaho ranked 50 th among states and the District of Columbia for mammography screening rates among women aged 50-74 and 51 st among ages 40+. Pap Test 2012, 2014, 2016 Statewide, 75.2% of women aged 21-65 (with intact cervix) reported having a Pap test in the past 3 years. Women with health insurance were significantly more likely to have timely Pap screening than uninsured women (78.0% versus 64.9% screened in the past 3 years). Pap screening differed significantly by county, with a range of 59.6% (Madison County) to 89.5% (Nez Perce County). In 2016, Idaho ranked 50 th among states and the District of Columbia for Pap screening rate. Colorectal Cancer Screening 2012, 2014, 2016 Statewide, 62.3% of adults aged 50-75 reported receiving colorectal cancer screening based on the most recent guidelines.** Persons with health insurance were over twice as likely to be current for colorectal cancer screening. In 2016, Idaho ranked 44 th among states and the District of Columbia in the percentage of adults aged 50-75 and older who reported being current with colorectal cancer screening recommendations. 5

Cancer Screening and Risk Factors Tobacco Use Current Smoking 2014-2016 Statewide, 14.7% of adults aged 18 and older were current smokers. Smoking prevalence differed significantly by age of respondent, with 19.0% of persons aged 30-39, and 8.2% of persons aged 65 and older, reporting current smoking. Smoking prevalence was lower among white non-hispanics (14.8%) than among Native Americans (28.3%). Smoking prevalence differed significantly by county, with a range of 3.8% (Madison County) to 32.6% (Washington County). Counties with higher rates of current smoking had higher rates of lung cancer. Smokeless Tobacco Use, Males 2012-2016 Statewide, 9.6% of males aged 18 and older were current users of smokeless tobacco. Smokeless tobacco use differed significantly by age group, ranging from 13.4% of males aged 30-39 to 4.2% of males aged 65 and older. Smokeless tobacco use differed significantly by county, with a range of 2.2% (Franklin County) to 24.5% (Custer County). Counties with higher rates of smokeless tobacco use had higher rates of oral cavity & pharynx cancer. Other Cancer-Related Sun Exposure 2016 Statewide, 24.4% of adults aged 18 and older reported having sunburn in the past 12 months. Sunburn rates were higher for white non-hispanics (26.1%) than for Hispanics (12.3%) or Native Americans (19.4%). Sunburn rates differed significantly by age group, with 38.3% of persons aged 18-29 and 6.0% of persons aged 65 and older having sunburn in the past 12 months. Sunburn rates differed significantly by county, with a range of 11.8% (Jerome County) to 47.0% (Minidoka County) having sunburn in the past 12 months. Weight Classification by Body Mass Index 2013-2016 Statewide, 32.7% of adults aged 20 and older were in the healthy weight range as measured by body mass index (BMI 18.5-24.9). BMI differed significantly by race/ethnicity, with 33.4% of white non-hispanics, compared to 25.9% of Hispanics and 27.0% of Native Americans, being in the healthy weight range. Males (25.8%) were significantly less likely to be in the healthy weight range than females (39.5%). BMI differed significantly by age of respondent, with 43.5% of persons aged 18-29, and 27.2% of persons aged 50-64, being in the healthy weight range. BMI differed significantly by county, with a range of 21.0% (Gem County) to 46.9% (Blaine County) of adults being in the healthy weight range. Counties with higher percentages of adults in the healthy weight range had significantly lower rates of colorectal cancer (p=.011). Physical Activity 2011, 2013, 2015 Statewide, 21.5% of adults aged 18 and older met aerobic and strength physical activity guidelines during the past month or week. Physical activity differed significantly by age of respondent, with 25.2% of persons aged 18-29, and 18.8% of persons aged 50-64, meeting guidelines. The percentage of adults meeting physical activity guidelines differed significantly by county, with a range of 7.6% (Oneida County) to 29.8% (Blaine County). Home Radon Testing 2014, 2016 Statewide, 18.6% of adults have ever tested their house for radon. Radon test usage varied significantly by race/ethnicity, with 20.2% of white non-hispanics, 4.9% of Hispanics, and 23.2% of Native Americans having ever tested their house for radon. Radon test usage was higher for persons aged 50-64 than for younger persons. Home radon testing differed significantly by county, with a range of 6.9% (Cassia County) to 50.2% (Blaine County). Artificial Tanning Appliance Use 2011, 2014, 2016 Statewide, 4.4% of adults aged 18 and older reported using an artificial tanning appliance, such as a tanning bed, in the past 12 months. Females (6.8%) were significantly more likely than males (2.1%) to have used an artificial tanning appliance in the past 12 months. Tanning appliance use differed significantly by age group, with 8.7% of persons aged 18-29 and 0.9% of persons aged 65 and older, using an appliance in the past 12 months. Tanning appliance use differed by county, with a range of less than 1% (Oneida, Power, and Valley Counties) to over 9% (Bear Lake, Fremont, and Madison Counties) using an artificial tanning appliance in the past 12 months. 6